Pyrido�3,4-e!-as-triazines
    1.
    发明授权
    Pyrido�3,4-e!-as-triazines 失效
    吡啶并[3,4-e] -as-三嗪

    公开(公告)号:US4424351A

    公开(公告)日:1984-01-03

    申请号:US123807

    申请日:1980-02-22

    CPC分类号: C07D471/04

    摘要: Acylated pyrido �3,4-e!-as-triazines of the formula (I), ##STR1## wherein R.sub.1 stands for alkyl, alkoxy, haloalkyl, furyl, pyridyl, phenyl, phenyl-(C.sub.1-4 alkyl) or phyenyl-(C.sub.2-4 alkenyl) optionally substituted. R.sub.2 stands for hydrogen or a group of the formula R.sub.1 --CO--, R.sub.3 stands for hydrogen, a phenyl group or a naphthy6l group optionally substituted, or a phenyl-(C.sub.1-4 alkyl) group, pyridyl group or a C.sub.1-20 alkyl group, and R.sub.4 stands for hydrogen or a group of the formula R.sub.1 --CO--, and R.sub.5 forms together with R.sub.2 or R.sub.4 a valence bond, wherein R.sub.2 or R.sub.4 taking part in forming said valence bond may not have the above meaning, and pharmaceutically acceptable acid addition salts thereof, which are prepared by reacting a pyrido �3,4-e!-as-triazine of the formula (II) or an acid addition salt thereof ##STR2## R.sub.6 stands for hydrogen, and R.sub.5 forms together with R.sub. and R.sub.4 a valence bond, with an acylating agent of the formula (III). R.sub.1 --CO--X (III) The compounds exert favourable effects on the central nervous system, and can be applied primarily as analgesic and antiphlogistic agents.

    摘要翻译: 式(I)的酰化吡啶并[3,4-e] -as-三嗪,其中R1代表烷基,烷氧基,卤代烷基,呋喃基,吡啶基,苯基,苯基 - (C1-4烷基)或 (烯基)(C 2-4烯基)任意取代。 R2代表氢或式R1-CO-的基团,R3代表氢,苯基或任选取代的萘基,或苯基 - (C 1-4烷基)基,吡啶基或C 1-20烷基, R4代表氢或式R1-CO-基团,R5与R2或R4一起形成价键,其中参与形成所述价键的R2或R4可能不具有上述含义,并且其药学上可接受的酸 通过使式(II)的吡啶并[3,4-e]-α-三嗪或其酸加成盐反应制备的加成盐,其中R6代表氢,R5与 兰德R4是价键,具有式(III)的酰化剂。 R1-CO-X(III)该化合物对中枢神经系统具有有利的作用,可主要用作镇痛药和消炎药。